Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of skeletal muscle contraction (GO:0014819) | 9.87164901 |
2 | actin-mediated cell contraction (GO:0070252) | 8.91618597 |
3 | sarcomere organization (GO:0045214) | 8.43717895 |
4 | skeletal muscle contraction (GO:0003009) | 7.92532293 |
5 | myofibril assembly (GO:0030239) | 7.38864671 |
6 | skeletal muscle adaptation (GO:0043501) | 7.08966633 |
7 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.05736503 |
8 | * sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.85640354 |
9 | plasma membrane repair (GO:0001778) | 6.85346164 |
10 | actin filament-based movement (GO:0030048) | 6.65488271 |
11 | striated muscle contraction (GO:0006941) | 6.55215166 |
12 | cardiac myofibril assembly (GO:0055003) | 6.52740732 |
13 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.37517069 |
14 | * regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.25920089 |
15 | carnitine shuttle (GO:0006853) | 6.10659281 |
16 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.00222526 |
17 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.92817287 |
18 | cardiac muscle contraction (GO:0060048) | 5.91724090 |
19 | regulation of relaxation of muscle (GO:1901077) | 5.90678911 |
20 | tricarboxylic acid cycle (GO:0006099) | 5.65440244 |
21 | actomyosin structure organization (GO:0031032) | 5.63144062 |
22 | * regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.40707454 |
23 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.40060911 |
24 | creatine metabolic process (GO:0006600) | 5.39883148 |
25 | * positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.36608101 |
26 | fatty acid transmembrane transport (GO:1902001) | 5.26759819 |
27 | regulation of actin filament-based movement (GO:1903115) | 5.15821524 |
28 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.11311443 |
29 | response to inactivity (GO:0014854) | 5.08861910 |
30 | cardiac muscle cell development (GO:0055013) | 5.08172425 |
31 | glycogen catabolic process (GO:0005980) | 4.97751241 |
32 | striated muscle atrophy (GO:0014891) | 4.94900280 |
33 | regulation of cofactor metabolic process (GO:0051193) | 4.91338835 |
34 | regulation of coenzyme metabolic process (GO:0051196) | 4.91338835 |
35 | * muscle contraction (GO:0006936) | 4.87812697 |
36 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.84405813 |
37 | cardiac cell development (GO:0055006) | 4.75846925 |
38 | response to muscle activity (GO:0014850) | 4.74161900 |
39 | skeletal muscle fiber development (GO:0048741) | 4.73961388 |
40 | striated muscle adaptation (GO:0014888) | 4.73468793 |
41 | glucan catabolic process (GO:0009251) | 4.65010022 |
42 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.64306143 |
43 | skeletal muscle tissue development (GO:0007519) | 4.62099790 |
44 | regulation of striated muscle contraction (GO:0006942) | 4.56747425 |
45 | carnitine transmembrane transport (GO:1902603) | 4.49997033 |
46 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.48971116 |
47 | skeletal muscle tissue regeneration (GO:0043403) | 4.47584026 |
48 | cytidine deamination (GO:0009972) | 4.45089145 |
49 | cytidine metabolic process (GO:0046087) | 4.45089145 |
50 | cytidine catabolic process (GO:0006216) | 4.45089145 |
51 | * muscle system process (GO:0003012) | 4.44124897 |
52 | cardiac muscle hypertrophy (GO:0003300) | 4.43712507 |
53 | striated muscle hypertrophy (GO:0014897) | 4.41873041 |
54 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.35908471 |
55 | * regulation of cell communication by electrical coupling (GO:0010649) | 4.35553185 |
56 | cellular polysaccharide catabolic process (GO:0044247) | 4.33911251 |
57 | regulation of sarcomere organization (GO:0060297) | 4.30182448 |
58 | muscle atrophy (GO:0014889) | 4.26584391 |
59 | muscle fiber development (GO:0048747) | 4.23664977 |
60 | muscle tissue morphogenesis (GO:0060415) | 4.17549875 |
61 | glucan biosynthetic process (GO:0009250) | 4.13386892 |
62 | glycogen biosynthetic process (GO:0005978) | 4.13386892 |
63 | myotube cell development (GO:0014904) | 4.13137688 |
64 | polysaccharide catabolic process (GO:0000272) | 4.11877057 |
65 | carnitine transport (GO:0015879) | 4.10053526 |
66 | amino-acid betaine transport (GO:0015838) | 4.10053526 |
67 | regulation of membrane repolarization (GO:0060306) | 4.01961090 |
68 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.01755805 |
69 | striated muscle cell development (GO:0055002) | 4.00396765 |
70 | regulation of sulfur metabolic process (GO:0042762) | 3.99982228 |
71 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.99897430 |
72 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.98908715 |
73 | muscle cell fate commitment (GO:0042693) | 3.92155124 |
74 | regulation of the force of heart contraction (GO:0002026) | 3.91866414 |
75 | muscle hypertrophy (GO:0014896) | 3.90603985 |
76 | adult heart development (GO:0007512) | 3.90470966 |
77 | muscle adaptation (GO:0043500) | 3.89025373 |
78 | oxidative phosphorylation (GO:0006119) | 3.78072309 |
79 | respiratory electron transport chain (GO:0022904) | 3.77748861 |
80 | muscle structure development (GO:0061061) | 3.74903858 |
81 | muscle organ development (GO:0007517) | 3.73927426 |
82 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.69629120 |
83 | electron transport chain (GO:0022900) | 3.66072841 |
84 | gluconeogenesis (GO:0006094) | 3.65615815 |
85 | glycogen metabolic process (GO:0005977) | 3.61686447 |
86 | positive regulation of myotube differentiation (GO:0010831) | 3.60787407 |
87 | response to activity (GO:0014823) | 3.59400490 |
88 | fructose metabolic process (GO:0006000) | 3.57928159 |
89 | heart trabecula formation (GO:0060347) | 3.55705404 |
90 | relaxation of muscle (GO:0090075) | 3.55382781 |
91 | glucan metabolic process (GO:0044042) | 3.54176877 |
92 | cellular glucan metabolic process (GO:0006073) | 3.54176877 |
93 | negative regulation of muscle hypertrophy (GO:0014741) | 3.53460114 |
94 | 2-oxoglutarate metabolic process (GO:0006103) | 3.51685443 |
95 | regulation of ATPase activity (GO:0043462) | 3.49271525 |
96 | regulation of ATP catabolic process (GO:1903289) | 3.49271525 |
97 | regulation of muscle system process (GO:0090257) | 3.44705162 |
98 | NADH metabolic process (GO:0006734) | 3.44017460 |
99 | regulation of sequestering of triglyceride (GO:0010889) | 3.43928539 |
100 | muscle cell cellular homeostasis (GO:0046716) | 3.43707099 |
101 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.41680618 |
102 | ATP synthesis coupled proton transport (GO:0015986) | 3.41680618 |
103 | muscle cell development (GO:0055001) | 3.41453982 |
104 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.40999647 |
105 | muscle hypertrophy in response to stress (GO:0003299) | 3.39372221 |
106 | cardiac muscle adaptation (GO:0014887) | 3.39372221 |
107 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.39372221 |
108 | muscle organ morphogenesis (GO:0048644) | 3.38927753 |
109 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.38571019 |
110 | * regulation of calcium ion transmembrane transport (GO:1903169) | 3.34981170 |
111 | * regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.34981170 |
112 | IMP metabolic process (GO:0046040) | 3.33609003 |
113 | striated muscle tissue development (GO:0014706) | 3.31706059 |
114 | regulation of muscle contraction (GO:0006937) | 3.31346764 |
115 | succinate metabolic process (GO:0006105) | 3.27426144 |
116 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.25747153 |
117 | regulation of myoblast differentiation (GO:0045661) | 3.25690677 |
118 | hexose biosynthetic process (GO:0019319) | 3.25478659 |
119 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.25105310 |
120 | negative regulation of protein localization to cell surface (GO:2000009) | 3.23819415 |
121 | relaxation of cardiac muscle (GO:0055119) | 3.23446213 |
122 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.17045166 |
123 | muscle filament sliding (GO:0030049) | 10.8036404 |
124 | actin-myosin filament sliding (GO:0033275) | 10.8036404 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.39062389 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.10592735 |
3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.14898089 |
4 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.09580587 |
5 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.79552573 |
6 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.65702383 |
7 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.65702383 |
8 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.60931964 |
9 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.96568470 |
10 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.85247180 |
11 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.81312830 |
12 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.70657159 |
13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.61136408 |
14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.52889519 |
15 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.43855406 |
16 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.30725863 |
17 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.15015445 |
18 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.10081586 |
19 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.81441459 |
20 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.73184952 |
21 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.69214273 |
22 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.67256508 |
23 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.66496703 |
24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.66257992 |
25 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.65980090 |
26 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.55918308 |
27 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.55897893 |
28 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.55084605 |
29 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.54962415 |
30 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.51019514 |
31 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.50726727 |
32 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.46616582 |
33 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.43247098 |
34 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.42657659 |
35 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.41202189 |
36 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.40538894 |
37 | GATA1_22025678_ChIP-Seq_K562_Human | 1.38479224 |
38 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.37187111 |
39 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.35723441 |
40 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.35138285 |
41 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.35122118 |
42 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.34113804 |
43 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.33908571 |
44 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.32367579 |
45 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.31930001 |
46 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.29813737 |
47 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.25635226 |
48 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.20117128 |
49 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.19475873 |
50 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.18761848 |
51 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.18139177 |
52 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.15308255 |
53 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.14544026 |
54 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.13725261 |
55 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.12554586 |
56 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.09234492 |
57 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08204324 |
58 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.05911616 |
59 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.05208259 |
60 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.04495259 |
61 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.04408793 |
62 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.03944057 |
63 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.03905770 |
64 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.03828075 |
65 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.03392706 |
66 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.02898798 |
67 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.02631664 |
68 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.02506873 |
69 | CJUN_26792858_Chip-Seq_BT549_Human | 1.01684649 |
70 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.01477305 |
71 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.01310433 |
72 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.99851826 |
73 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.99845200 |
74 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.98947744 |
75 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.96760319 |
76 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.95555294 |
77 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.94949003 |
78 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.93017696 |
79 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.92896532 |
80 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.92702625 |
81 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.92688229 |
82 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.92073842 |
83 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.91689518 |
84 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91535113 |
85 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.91344938 |
86 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.90482485 |
87 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90163383 |
88 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.89782886 |
89 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.89532120 |
90 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.89226076 |
91 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.88420887 |
92 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.88135037 |
93 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.87673429 |
94 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.87596458 |
95 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.87516056 |
96 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.87486503 |
97 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.86690373 |
98 | ATF3_27146783_Chip-Seq_COLON_Human | 0.86650796 |
99 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.86083492 |
100 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.84823906 |
101 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.84694661 |
102 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.83114054 |
103 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82974568 |
104 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.82538612 |
105 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.82182281 |
106 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.82115798 |
107 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.81472911 |
108 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.81472911 |
109 | SA1_27219007_Chip-Seq_Bcells_Human | 0.80864437 |
110 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.80320344 |
111 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.80267362 |
112 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.80198763 |
113 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.79806839 |
114 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.78443212 |
115 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.78209453 |
116 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 0.77914072 |
117 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 0.77914072 |
118 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.77838213 |
119 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.76769185 |
120 | P68_20966046_ChIP-Seq_HELA_Human | 0.76469892 |
121 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76303832 |
122 | GATA1_19941826_ChIP-Seq_K562_Human | 0.75938264 |
123 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.75812092 |
124 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.75784609 |
125 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.75758768 |
126 | VDR_22108803_ChIP-Seq_LS180_Human | 0.75590368 |
127 | CBP_21632823_ChIP-Seq_H3396_Human | 0.75444445 |
128 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.74938251 |
129 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.74905617 |
130 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.74889831 |
131 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.74526225 |
132 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.74523234 |
133 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.74503361 |
134 | NFYB_21822215_ChIP-Seq_K562_Human | 0.73694153 |
135 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.73259245 |
136 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.73258701 |
137 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.73158628 |
138 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.73010609 |
139 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.72587617 |
140 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.72488495 |
141 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.72349220 |
142 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.69891450 |
143 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.69638031 |
144 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.69638031 |
145 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.69168575 |
146 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.68715537 |
147 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.68624435 |
148 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.68150219 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003646_muscle_fatigue | 6.36788215 |
2 | MP0000751_myopathy | 5.70364045 |
3 | MP0000749_muscle_degeneration | 5.64067618 |
4 | MP0002837_dystrophic_cardiac_calcinosis | 5.08579039 |
5 | * MP0004145_abnormal_muscle_electrophysio | 4.66635847 |
6 | MP0004036_abnormal_muscle_relaxation | 4.51226106 |
7 | MP0004084_abnormal_cardiac_muscle | 4.03596662 |
8 | * MP0002106_abnormal_muscle_physiology | 3.60041460 |
9 | MP0000747_muscle_weakness | 3.53620408 |
10 | * MP0004087_abnormal_muscle_fiber | 3.47682204 |
11 | MP0004215_abnormal_myocardial_fiber | 3.36283733 |
12 | MP0004130_abnormal_muscle_cell | 3.29248108 |
13 | MP0005620_abnormal_muscle_contractility | 3.21090444 |
14 | MP0000750_abnormal_muscle_regeneration | 3.20837766 |
15 | MP0002269_muscular_atrophy | 3.20464784 |
16 | MP0005330_cardiomyopathy | 3.19375125 |
17 | * MP0000759_abnormal_skeletal_muscle | 3.07769501 |
18 | * MP0005369_muscle_phenotype | 2.97112607 |
19 | MP0002972_abnormal_cardiac_muscle | 2.45048635 |
20 | MP0004233_abnormal_muscle_weight | 2.40165907 |
21 | MP0004484_altered_response_of | 2.23240805 |
22 | MP0006036_abnormal_mitochondrial_physio | 2.14274667 |
23 | MP0010630_abnormal_cardiac_muscle | 2.09657496 |
24 | MP0003137_abnormal_impulse_conducting | 2.00212601 |
25 | MP0002332_abnormal_exercise_endurance | 1.99465577 |
26 | MP0005385_cardiovascular_system_phenoty | 1.92459379 |
27 | MP0001544_abnormal_cardiovascular_syste | 1.92459379 |
28 | MP0008775_abnormal_heart_ventricle | 1.92039187 |
29 | MP0003221_abnormal_cardiomyocyte_apopto | 1.83590759 |
30 | MP0000733_abnormal_muscle_development | 1.63126823 |
31 | MP0002108_abnormal_muscle_morphology | 1.61859845 |
32 | MP0006138_congestive_heart_failure | 1.48867668 |
33 | MP0005666_abnormal_adipose_tissue | 1.47221781 |
34 | MP0003950_abnormal_plasma_membrane | 1.44681349 |
35 | MP0004185_abnormal_adipocyte_glucose | 1.43262892 |
36 | MP0003828_pulmonary_edema | 1.41640802 |
37 | MP0004510_myositis | 1.33976934 |
38 | MP0004085_abnormal_heartbeat | 1.32304954 |
39 | MP0002127_abnormal_cardiovascular_syste | 1.27108047 |
40 | MP0001661_extended_life_span | 1.23293033 |
41 | MP0006035_abnormal_mitochondrial_morpho | 1.16335753 |
42 | MP0002971_abnormal_brown_adipose | 1.10613100 |
43 | MP0005375_adipose_tissue_phenotype | 1.02392909 |
44 | MP0005266_abnormal_metabolism | 1.00494285 |
45 | MP0002234_abnormal_pharynx_morphology | 0.99507686 |
46 | MP0003567_abnormal_fetal_cardiomyocyte | 0.96417524 |
47 | MP0005670_abnormal_white_adipose | 0.95245578 |
48 | MP0000343_altered_response_to | 0.93397024 |
49 | MP0000266_abnormal_heart_morphology | 0.92648458 |
50 | MP0003806_abnormal_nucleotide_metabolis | 0.90846818 |
51 | MP0000013_abnormal_adipose_tissue | 0.81662060 |
52 | MP0004043_abnormal_pH_regulation | 0.79740126 |
53 | MP0002822_catalepsy | 0.74687274 |
54 | MP0005165_increased_susceptibility_to | 0.68486653 |
55 | MP0003705_abnormal_hypodermis_morpholog | 0.66641468 |
56 | MP0005275_abnormal_skin_tensile | 0.66366840 |
57 | MP0004147_increased_porphyrin_level | 0.64533290 |
58 | MP0000230_abnormal_systemic_arterial | 0.57752537 |
59 | MP0002078_abnormal_glucose_homeostasis | 0.57206622 |
60 | MP0000003_abnormal_adipose_tissue | 0.55462374 |
61 | MP0002128_abnormal_blood_circulation | 0.53333399 |
62 | MP0004270_analgesia | 0.51457958 |
63 | MP0008961_abnormal_basal_metabolism | 0.50091469 |
64 | MP0005334_abnormal_fat_pad | 0.49193826 |
65 | MP0005451_abnormal_body_composition | 0.47652909 |
66 | MP0001299_abnormal_eye_distance/ | 0.43767819 |
67 | MP0003941_abnormal_skin_development | 0.43559969 |
68 | MP0010030_abnormal_orbit_morphology | 0.43059441 |
69 | MP0005319_abnormal_enzyme/_coenzyme | 0.42347430 |
70 | MP0010368_abnormal_lymphatic_system | 0.40902863 |
71 | MP0003656_abnormal_erythrocyte_physiolo | 0.40494481 |
72 | MP0003566_abnormal_cell_adhesion | 0.40215182 |
73 | MP0003879_abnormal_hair_cell | 0.39285964 |
74 | MP0000762_abnormal_tongue_morphology | 0.38763696 |
75 | MP0003279_aneurysm | 0.38133652 |
76 | MP0003045_fibrosis | 0.37359768 |
77 | MP0001879_abnormal_lymphatic_vessel | 0.36509319 |
78 | MP0004142_abnormal_muscle_tone | 0.36246544 |
79 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.35017607 |
80 | MP0003948_abnormal_gas_homeostasis | 0.34423809 |
81 | MP0005452_abnormal_adipose_tissue | 0.34403312 |
82 | MP0002638_abnormal_pupillary_reflex | 0.33634844 |
83 | MP0005167_abnormal_blood-brain_barrier | 0.33601151 |
84 | MP0009250_abnormal_appendicular_skeleto | 0.33317299 |
85 | MP0002114_abnormal_axial_skeleton | 0.31979642 |
86 | MP0004134_abnormal_chest_morphology | 0.31507224 |
87 | MP0005187_abnormal_penis_morphology | 0.29874558 |
88 | MP0009115_abnormal_fat_cell | 0.29800510 |
89 | MP0008438_abnormal_cutaneous_collagen | 0.29661514 |
90 | MP0000372_irregular_coat_pigmentation | 0.28979889 |
91 | MP0005535_abnormal_body_temperature | 0.28872302 |
92 | MP0002909_abnormal_adrenal_gland | 0.28381556 |
93 | MP0002925_abnormal_cardiovascular_devel | 0.27677414 |
94 | MP0005503_abnormal_tendon_morphology | 0.26758043 |
95 | MP0005623_abnormal_meninges_morphology | 0.25503647 |
96 | MP0001984_abnormal_olfaction | 0.24750910 |
97 | MP0003195_calcinosis | 0.24646267 |
98 | MP0005083_abnormal_biliary_tract | 0.24423075 |
99 | MP0000767_abnormal_smooth_muscle | 0.24351303 |
100 | MP0008569_lethality_at_weaning | 0.24031003 |
101 | MP0002896_abnormal_bone_mineralization | 0.23974579 |
102 | MP0001784_abnormal_fluid_regulation | 0.23821634 |
103 | MP0005332_abnormal_amino_acid | 0.23202754 |
104 | MP0002118_abnormal_lipid_homeostasis | 0.23106774 |
105 | MP0002734_abnormal_mechanical_nocicepti | 0.22526649 |
106 | MP0000579_abnormal_nail_morphology | 0.22016752 |
107 | MP0009780_abnormal_chondrocyte_physiolo | 0.22010014 |
108 | MP0003959_abnormal_lean_body | 0.21969997 |
109 | MP0009672_abnormal_birth_weight | 0.21424225 |
110 | MP0005376_homeostasis/metabolism_phenot | 0.21402644 |
111 | MP0001614_abnormal_blood_vessel | 0.20988528 |
112 | MP0005423_abnormal_somatic_nervous | 0.20194316 |
113 | MP0005166_decreased_susceptibility_to | 0.19929123 |
114 | MP0001943_abnormal_respiration | 0.18282227 |
115 | MP0001853_heart_inflammation | 0.18266568 |
116 | MP0004197_abnormal_fetal_growth/weight/ | 0.17289743 |
117 | MP0001346_abnormal_lacrimal_gland | 0.15075660 |
118 | * MP0002066_abnormal_motor_capabilities/c | 0.14972590 |
119 | MP0006276_abnormal_autonomic_nervous | 0.14845802 |
120 | MP0008770_decreased_survivor_rate | 0.13976337 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Exercise-induced myalgia (HP:0003738) | 8.24033319 |
2 | Muscle fiber inclusion bodies (HP:0100299) | 7.90044140 |
3 | Exercise-induced muscle cramps (HP:0003710) | 7.81828588 |
4 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.61197885 |
5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 7.01871844 |
6 | Nemaline bodies (HP:0003798) | 7.00043511 |
7 | Calf muscle hypertrophy (HP:0008981) | 6.74731586 |
8 | Type 1 muscle fiber predominance (HP:0003803) | 6.01724665 |
9 | Muscle fiber splitting (HP:0003555) | 5.74966497 |
10 | Myoglobinuria (HP:0002913) | 5.61573423 |
11 | Distal arthrogryposis (HP:0005684) | 5.46876037 |
12 | Hyporeflexia of lower limbs (HP:0002600) | 5.25389058 |
13 | Sudden death (HP:0001699) | 5.20606694 |
14 | Difficulty running (HP:0009046) | 5.01536801 |
15 | Abnormality of the calf musculature (HP:0001430) | 4.96722466 |
16 | Myopathic facies (HP:0002058) | 4.91479013 |
17 | EMG: myopathic abnormalities (HP:0003458) | 4.78110580 |
18 | Round ear (HP:0100830) | 4.65460314 |
19 | Rhabdomyolysis (HP:0003201) | 4.59432071 |
20 | Subaortic stenosis (HP:0001682) | 4.42774443 |
21 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.42774443 |
22 | Ulnar deviation of the wrist (HP:0003049) | 4.38314928 |
23 | Increased connective tissue (HP:0009025) | 4.34423820 |
24 | Ventricular tachycardia (HP:0004756) | 4.26225700 |
25 | Muscle stiffness (HP:0003552) | 4.20417686 |
26 | Myotonia (HP:0002486) | 3.98704323 |
27 | Calcaneovalgus deformity (HP:0001848) | 3.69466739 |
28 | Asymmetric septal hypertrophy (HP:0001670) | 3.60870243 |
29 | Absent phalangeal crease (HP:0006109) | 3.50770718 |
30 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.42420963 |
31 | Deformed tarsal bones (HP:0008119) | 3.38937160 |
32 | Neck muscle weakness (HP:0000467) | 3.35994345 |
33 | Difficulty climbing stairs (HP:0003551) | 3.32339627 |
34 | Lipoatrophy (HP:0100578) | 3.31632986 |
35 | Atrial fibrillation (HP:0005110) | 3.25118589 |
36 | Rimmed vacuoles (HP:0003805) | 3.24074496 |
37 | Increased variability in muscle fiber diameter (HP:0003557) | 3.22527872 |
38 | Areflexia of lower limbs (HP:0002522) | 3.16461100 |
39 | Primary atrial arrhythmia (HP:0001692) | 3.02690020 |
40 | Supraventricular tachycardia (HP:0004755) | 2.91759785 |
41 | Right ventricular cardiomyopathy (HP:0011663) | 2.91264175 |
42 | Dilated cardiomyopathy (HP:0001644) | 2.90603241 |
43 | Abnormal finger flexion creases (HP:0006143) | 2.88746681 |
44 | Supraventricular arrhythmia (HP:0005115) | 2.84856139 |
45 | Bundle branch block (HP:0011710) | 2.80002772 |
46 | Distal lower limb muscle weakness (HP:0009053) | 2.76465721 |
47 | Frequent falls (HP:0002359) | 2.63650761 |
48 | Malignant hyperthermia (HP:0002047) | 2.60629357 |
49 | Palpitations (HP:0001962) | 2.58956980 |
50 | Fetal akinesia sequence (HP:0001989) | 2.54088332 |
51 | Syncope (HP:0001279) | 2.50806483 |
52 | Ventricular arrhythmia (HP:0004308) | 2.45875462 |
53 | Hypoplastic ischia (HP:0003175) | 2.45723886 |
54 | EMG: neuropathic changes (HP:0003445) | 2.41606426 |
55 | Prolonged QT interval (HP:0001657) | 2.40753728 |
56 | Muscular dystrophy (HP:0003560) | 2.38713251 |
57 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.34746272 |
58 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.34746272 |
59 | Heart block (HP:0012722) | 2.32916484 |
60 | Generalized muscle weakness (HP:0003324) | 2.31807883 |
61 | Hyperkalemia (HP:0002153) | 2.30355255 |
62 | Pelvic girdle muscle weakness (HP:0003749) | 2.30342338 |
63 | Hip contracture (HP:0003273) | 2.29437145 |
64 | Shoulder girdle muscle weakness (HP:0003547) | 2.29157547 |
65 | Limb-girdle muscle atrophy (HP:0003797) | 2.24361066 |
66 | Facial diplegia (HP:0001349) | 2.22351825 |
67 | Abnormal atrioventricular conduction (HP:0005150) | 2.20058067 |
68 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.19885638 |
69 | Gowers sign (HP:0003391) | 2.19443946 |
70 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.15991781 |
71 | Abnormality of the ischium (HP:0003174) | 2.14386989 |
72 | Abnormality of the foot musculature (HP:0001436) | 2.13778039 |
73 | Abnormality of the neuromuscular junction (HP:0003398) | 2.13463326 |
74 | Fatigable weakness (HP:0003473) | 2.13463326 |
75 | Proximal amyotrophy (HP:0007126) | 2.13350008 |
76 | Acute necrotizing encephalopathy (HP:0006965) | 2.11972008 |
77 | Abnormality of the calcaneus (HP:0008364) | 2.11026072 |
78 | Limb-girdle muscle weakness (HP:0003325) | 2.07584578 |
79 | Scapular winging (HP:0003691) | 2.07312598 |
80 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.04685253 |
81 | Progressive muscle weakness (HP:0003323) | 2.03122637 |
82 | Exercise intolerance (HP:0003546) | 2.02169475 |
83 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.01236186 |
84 | Waddling gait (HP:0002515) | 2.00273607 |
85 | Distal lower limb amyotrophy (HP:0008944) | 1.98100738 |
86 | Foot dorsiflexor weakness (HP:0009027) | 1.95615741 |
87 | Hepatic necrosis (HP:0002605) | 1.93903786 |
88 | Atrioventricular block (HP:0001678) | 1.93556250 |
89 | Spinal rigidity (HP:0003306) | 1.93446470 |
90 | Bulbar palsy (HP:0001283) | 1.91080008 |
91 | Left ventricular hypertrophy (HP:0001712) | 1.90722660 |
92 | Lower limb amyotrophy (HP:0007210) | 1.90120925 |
93 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.86365792 |
94 | Slender build (HP:0001533) | 1.85731329 |
95 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.84896003 |
96 | Ragged-red muscle fibers (HP:0003200) | 1.82684777 |
97 | Paralysis (HP:0003470) | 1.82618760 |
98 | Ventricular fibrillation (HP:0001663) | 1.82275990 |
99 | Acute encephalopathy (HP:0006846) | 1.81305541 |
100 | Weak cry (HP:0001612) | 1.79819217 |
101 | Abnormal EKG (HP:0003115) | 1.78161429 |
102 | Ketoacidosis (HP:0001993) | 1.76821989 |
103 | Progressive macrocephaly (HP:0004481) | 1.76764841 |
104 | Increased muscle lipid content (HP:0009058) | 1.74009485 |
105 | Long clavicles (HP:0000890) | 1.72138952 |
106 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.71557934 |
107 | Abnormality of alanine metabolism (HP:0010916) | 1.71557934 |
108 | Hyperalaninemia (HP:0003348) | 1.71557934 |
109 | Hepatocellular necrosis (HP:0001404) | 1.70166744 |
110 | Metatarsus adductus (HP:0001840) | 1.66319182 |
111 | Popliteal pterygium (HP:0009756) | 1.64603027 |
112 | Oligomenorrhea (HP:0000876) | 1.64031044 |
113 | Nonprogressive disorder (HP:0003680) | 1.62352206 |
114 | Ulnar deviation of finger (HP:0009465) | 1.61878730 |
115 | Type 2 muscle fiber atrophy (HP:0003554) | 1.56737228 |
116 | Limited hip movement (HP:0008800) | 1.56032111 |
117 | Steppage gait (HP:0003376) | 1.51125978 |
118 | Increased intramyocellular lipid droplets (HP:0012240) | 1.45641722 |
Rank | Gene Set | Z-score |
---|---|---|
1 | OBSCN | 7.83938882 |
2 | TTN | 6.36752180 |
3 | PHKG2 | 5.15094147 |
4 | PHKG1 | 5.15094147 |
5 | PDK4 | 2.89090287 |
6 | PDK3 | 2.89090287 |
7 | NME1 | 2.86711909 |
8 | PIK3CG | 2.51121922 |
9 | NEK1 | 2.47223880 |
10 | DMPK | 2.43423796 |
11 | PINK1 | 2.24861156 |
12 | MAP2K3 | 2.16757025 |
13 | TRIB3 | 2.14212030 |
14 | PIK3CA | 2.06128814 |
15 | BCKDK | 2.04763703 |
16 | STK24 | 1.85247054 |
17 | MUSK | 1.84295486 |
18 | PDK2 | 1.83165894 |
19 | MAP3K7 | 1.80117362 |
20 | PKN2 | 1.74927261 |
21 | MYLK | 1.59174643 |
22 | MAPK12 | 1.43355803 |
23 | LMTK2 | 1.33028035 |
24 | ZAK | 1.16861223 |
25 | MAP2K4 | 1.08662307 |
26 | TIE1 | 1.03168259 |
27 | PRKAA2 | 0.98291615 |
28 | EEF2K | 0.96434252 |
29 | MARK1 | 0.95586949 |
30 | ILK | 0.94593102 |
31 | TRPM7 | 0.92922646 |
32 | PRKAA1 | 0.90868324 |
33 | MAP2K6 | 0.89878327 |
34 | CCNB1 | 0.88039264 |
35 | NEK9 | 0.82207891 |
36 | GRK7 | 0.81042866 |
37 | MAP3K3 | 0.80526646 |
38 | MAPKAPK3 | 0.75822566 |
39 | MOS | 0.74210602 |
40 | CAMK2D | 0.66751386 |
41 | PRKD1 | 0.63910669 |
42 | INSRR | 0.62090395 |
43 | MAP3K5 | 0.57476185 |
44 | AKT2 | 0.55150542 |
45 | ROCK1 | 0.54812437 |
46 | PAK3 | 0.54055541 |
47 | DYRK1B | 0.53625280 |
48 | CAMK2G | 0.53214104 |
49 | PKN1 | 0.52094666 |
50 | STK38L | 0.51788973 |
51 | RIPK1 | 0.50767399 |
52 | TAOK2 | 0.49465334 |
53 | FLT3 | 0.45498741 |
54 | LIMK1 | 0.43587581 |
55 | MAPK11 | 0.43571074 |
56 | CAMK2B | 0.40441606 |
57 | EPHB1 | 0.39197076 |
58 | MAP3K13 | 0.38758607 |
59 | PRKACB | 0.37766308 |
60 | WNK1 | 0.34501469 |
61 | ERBB3 | 0.33666887 |
62 | CAMK4 | 0.32833720 |
63 | SGK2 | 0.32645874 |
64 | PRKACA | 0.31301367 |
65 | MAP3K11 | 0.30888891 |
66 | CDC42BPA | 0.30310112 |
67 | NLK | 0.29849050 |
68 | WNK4 | 0.28926297 |
69 | SGK1 | 0.28068749 |
70 | SIK1 | 0.27662157 |
71 | TGFBR2 | 0.27545824 |
72 | TNIK | 0.27537683 |
73 | PTK6 | 0.27420689 |
74 | PRKG1 | 0.26358791 |
75 | CAMK2A | 0.25914890 |
76 | PDPK1 | 0.25781990 |
77 | PDGFRA | 0.24766046 |
78 | TAOK1 | 0.24059545 |
79 | PDK1 | 0.23749433 |
80 | ROCK2 | 0.22970081 |
81 | MAPK10 | 0.22015495 |
82 | CAMK1 | 0.21830422 |
83 | MAPK7 | 0.21171054 |
84 | PRKACG | 0.20980873 |
85 | MAPK13 | 0.20958035 |
86 | RPS6KA3 | 0.20621222 |
87 | MAP3K6 | 0.20448216 |
88 | TBK1 | 0.20016437 |
89 | RPS6KB1 | 0.19977280 |
90 | STK38 | 0.18977162 |
91 | RPS6KA1 | 0.17049494 |
92 | PTK2B | 0.16976382 |
93 | LATS1 | 0.16920457 |
94 | RPS6KB2 | 0.16918212 |
95 | NME2 | 0.16629660 |
96 | STK4 | 0.15505055 |
97 | MAP3K1 | 0.15078115 |
98 | DAPK3 | 0.14601483 |
99 | STK11 | 0.12543010 |
100 | MAP2K1 | 0.12095854 |
101 | LATS2 | 0.11932334 |
102 | FER | 0.11581425 |
103 | MARK3 | 0.11411792 |
104 | SGK494 | 0.10708517 |
105 | SGK223 | 0.10708517 |
106 | MARK2 | 0.10519114 |
107 | STK39 | 0.10487890 |
108 | MAP3K10 | 0.10093797 |
109 | FGFR1 | 0.09218254 |
110 | RAF1 | 0.09192017 |
111 | MAPK4 | 0.09131482 |
112 | SGK3 | 0.08888030 |
113 | RPS6KL1 | 0.08772588 |
114 | RPS6KC1 | 0.08772588 |
115 | MTOR | 0.06928928 |
116 | KDR | 0.06762252 |
117 | BMPR1B | 0.05647756 |
118 | KSR2 | 0.05462828 |
119 | DAPK2 | 0.04912935 |
120 | EPHA3 | 0.04822659 |
121 | PRKCH | 0.04447977 |
122 | PRKDC | 0.04293183 |
123 | ICK | 0.04189050 |
124 | RET | 0.04097223 |
125 | RPS6KA6 | 0.03872522 |
126 | PRKG2 | 0.03012940 |
127 | GSK3B | 0.02762116 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.47526794 |
2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.27300350 |
3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.03446118 |
4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.84870606 |
5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.66999460 |
6 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.15511601 |
7 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.15363436 |
8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.93581368 |
9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.75378019 |
10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.61200005 |
11 | Carbon metabolism_Homo sapiens_hsa01200 | 2.46377627 |
12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.37034132 |
13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.30845817 |
14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.16279391 |
15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.09778160 |
16 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.93769405 |
17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.84281981 |
18 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.76903910 |
19 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.70053411 |
20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.69750364 |
21 | Huntingtons disease_Homo sapiens_hsa05016 | 1.69564990 |
22 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.64688063 |
23 | Viral myocarditis_Homo sapiens_hsa05416 | 1.55972090 |
24 | Insulin resistance_Homo sapiens_hsa04931 | 1.55120615 |
25 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.52432670 |
26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.38995448 |
27 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.33188033 |
28 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.31725598 |
29 | Circadian rhythm_Homo sapiens_hsa04710 | 1.30375016 |
30 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.27331183 |
31 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.20403719 |
32 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.14341905 |
33 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.13914176 |
34 | Galactose metabolism_Homo sapiens_hsa00052 | 1.12446783 |
35 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.07862632 |
36 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.99386416 |
37 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.98022089 |
38 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.92843457 |
39 | Tight junction_Homo sapiens_hsa04530 | 0.90135740 |
40 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.86700464 |
41 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.86512485 |
42 | Focal adhesion_Homo sapiens_hsa04510 | 0.83540510 |
43 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.83089175 |
44 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.82230167 |
45 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.80688562 |
46 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.78789163 |
47 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.77967913 |
48 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.70669502 |
49 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.70619829 |
50 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.67562570 |
51 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.62011185 |
52 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58853911 |
53 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.57628756 |
54 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.56209001 |
55 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.52420133 |
56 | Renin secretion_Homo sapiens_hsa04924 | 0.49060471 |
57 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.47981939 |
58 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47780597 |
59 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47644354 |
60 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46138576 |
61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.44798710 |
62 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.43380323 |
63 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.42251437 |
64 | Lysine degradation_Homo sapiens_hsa00310 | 0.41562768 |
65 | Adherens junction_Homo sapiens_hsa04520 | 0.39788969 |
66 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39362789 |
67 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.36545981 |
68 | Salivary secretion_Homo sapiens_hsa04970 | 0.35316431 |
69 | Insulin secretion_Homo sapiens_hsa04911 | 0.35040410 |
70 | Peroxisome_Homo sapiens_hsa04146 | 0.34642582 |
71 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.33673071 |
72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32817280 |
73 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.31390787 |
74 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.31058596 |
75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.30997991 |
76 | Platelet activation_Homo sapiens_hsa04611 | 0.28870983 |
77 | Amoebiasis_Homo sapiens_hsa05146 | 0.27766056 |
78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.27080550 |
79 | Purine metabolism_Homo sapiens_hsa00230 | 0.24730167 |
80 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.24538591 |
81 | Histidine metabolism_Homo sapiens_hsa00340 | 0.24118976 |
82 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.23021659 |
83 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.22642729 |
84 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.22158426 |
85 | Long-term depression_Homo sapiens_hsa04730 | 0.21738776 |
86 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.21662100 |
87 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.21531903 |
88 | Metabolic pathways_Homo sapiens_hsa01100 | 0.21483560 |
89 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.20939189 |
90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.20638785 |
91 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.19669022 |
92 | Olfactory transduction_Homo sapiens_hsa04740 | 0.18290282 |
93 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.17579754 |
94 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.16618390 |
95 | Circadian entrainment_Homo sapiens_hsa04713 | 0.12494936 |
96 | Phototransduction_Homo sapiens_hsa04744 | 0.10917794 |
97 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.09406908 |
98 | Glioma_Homo sapiens_hsa05214 | 0.08952588 |
99 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.08145218 |
100 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.06855614 |
101 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.06710019 |
102 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.06646232 |
103 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.05711286 |
104 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.05344667 |
105 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.05014698 |
106 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.00309169 |
107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0716053 |
108 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0711202 |
109 | Long-term potentiation_Homo sapiens_hsa04720 | -0.0709535 |
110 | Bile secretion_Homo sapiens_hsa04976 | -0.0601998 |
111 | Melanogenesis_Homo sapiens_hsa04916 | -0.0392551 |
112 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | -0.0335936 |
113 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | -0.0206930 |
114 | Gap junction_Homo sapiens_hsa04540 | -0.0091011 |
115 | Sulfur metabolism_Homo sapiens_hsa00920 | -0.0026869 |
116 | Toxoplasmosis_Homo sapiens_hsa05145 | -0.0022428 |